Pardeep Nijhawan, Chief Executive Officer, 10% Owner at Edesa Biotech, Inc. (EDSA), bought 2,000 shares at $3.05 ($6K) on 2022-03-30, disclosed to the SEC on 2022-03-31.
Open-market purchase of $6k EDSA by Chief Executive Officer, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| EDSA | BUY | 2026-03-05 | $43K | — | Filing → |
| EDSA | BUY | 2026-03-04 | $36K | — | Filing → |
| EDSA | BUY | 2026-03-03 | $6K | — | Filing → |